People · Operator
Named in public records as an officer, director or promoter · active 2019–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NemaMetrix Inc. | — | Biotechnology | Series A | $9.6M | $186.6M | 2019 |
| CytoImage Inc. | — | Biotechnology | Pre-Seed | $225K | $6.8M | 2021 |
Ann Bunnenberg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ann Bunnenberg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| RICK MILLER | 1 | 4 |
| Kevin Padrick | 1 | 3 |
| Chris Carlson | 1 | 2 |
| Matt Beaudet | 1 | 2 |
| Sandra Shotwell | 1 | 2 |
| Evangeline Gonzalez | 1 | 2 |
| Chris Hopkins | 1 | 2 |
| Tania Vu | 1 | 1 |
| Janis Weeks | 1 | 1 |
| Trisha Brock | 1 | 1 |
| Amy Tykeson | 1 | 1 |
| Shawn Lockery | 1 | 1 |
| Lynnor Stevenson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.